NT-proBNP/urine hepcidin-25 ratio and cardiorenal syndrome type 1 in patients with severe symptomatic aortic stenosis

被引：2

作者：

Nuebel, Jonathan ^{[1
,2
]}

Hoffmeister, Meike ^{[3
,4
,5
]}

Labrenz, Oliver ^{[6
]}

Jost, Kerstin ^{[6
]}

Oess, Stefanie ^{[3
,4
,5
]}

Hauptmann, Michael ^{[4
,5
,7
]}

Schoen, Julika ^{[8
]}

Fritz, Georg ^{[9
]}

Haase, Michael ^{[10
,11
,12
]}

Butter, Christian ^{[1
,2
,4
,5
]}

Haase-Fielitz, Anja ^{[1
,2
,4
,5
,12
]}

机构：

[1] Univ Hosp Heart Ctr Brandenburg, Dept Cardiovasc, D-16321 Bernau, Germany

[2] Brandenburg Med Sch MHB, Fac Hlth Sci Brandenburg, D-16321 Bernau, Germany

[3] Brandenburg Med Sch MHB, Inst Biochem, D-14770 Brandenburg, Germany

[4] Univ Potsdam, Joint Fac, Fac Hlth Sci FGW, Brandenburg Med Sch, Cottbus, Germany

[5] Brandenburg Tech Univ Cottbus Senftenberg, Cottbus, Germany

[6] Univ Hosp Ruppin Brandenburg, Brandenburg Med Sch MHB, Dept Psychol, D-16816 Neuruppin, Germany

[7] Brandenburg Med Sch MHB, Inst Biostat & Registry Res, D-16816 Neuruppin, Germany

[8] Univ Hosp Ruppin Brandenburg, Brandenburg Med Sch MHB, Anesthesia & Intens Care, D-16816 Neuruppin, Germany

[9] Univ Hosp Heart Ctr Brandenburg, Brandenburg Med Sch MHB, Dept Anesthesiol Intens Care & Pain Therapy, D-16321 Bernau, Germany

[10] Diamedikum Kidney Care Ctr, D-14473 Potsdam, Germany

[11] Hannover Med Sch, Dept Nephrol & Hypertens, DE-30625 Hannover, Germany

[12] Otto von Guericke Univ, Inst Social Med & Hlth Syst Res, D-39120 Magdeburg, Germany

来源：

BIOMARKERS IN MEDICINE | 2023年 / 17卷 / 10期

关键词：

acute kidney injury; aortic stenosis; biomarker ratio; cardiorenal syndrome; hepcidin; NT-proBNP; TAVI; ACUTE KIDNEY INJURY; CONSENSUS CONFERENCE; RISK; DEFINITIONS; BIOMARKERS; MANAGEMENT;

D O I：

10.2217/bmm-2023-0034

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background: This study aimed to determine whether novel and conventional cardiorenal biomarkers in patients before transcatheter aortic valve implantation may be associated with cardiorenal syndrome (CRS) type 1. Methods: Serum NT-proBNP and urine biomarkers (hepcidin-25, NGAL, IL-6) were measured before and 24 h after transcatheter aortic valve implantation. Results: 16/95 patients had CRS type 1. Those patients had longer length of stay in hospital (12.5 [9.0-16.0] vs 9.0 [8-12] days; p = 0.025) and were more frequently readmitted to hospital within 6 months after discharge (46.7 vs 15.6%; odds ratio: 4.7; 95% CI: 1.5-15.5; p = 0.007). The NT-proBNP/urine hepcidin-25 ratio (odds ratio: 2.89; 95% CI: 1.30-6.41; p = 0.009) was an independent modifier of CRS type 1. Conclusion: The NT-proBNP/urine hepcidin-25 ratio appears to be a modifier of risk of CRS type 1.

引用

页码：475 / 485

页数：11

共 50 条

[31] Serumcopeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study
Melena, Isabella
Bjornstad, Petter
Schafer, Michal
Hunter, Kendall S.
Barker, Alex J.
Baumgartner, Amy
Chung, Linh
Wiromrat, Pattara
Truong, Uyen
Reusch, Jane E. B.
Nadeau, Kristen J.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (05)
[32] Cardiorenal Syndrome Patients With High NT-proBNP and Cystatin C Levels and Patients With Irreversible Cardiorenal Syndrome Identified by Persistently High Levels of Cystatin C Have Worse Outcomes in Cardiac Resynchronization Therapy: The BIOCRT Study
Contractor, Jigar
Szymonifka, Jackie
Deano, Roderick C.
Chatterjee, Neal A.
Januzzi, James L.
Singh, Jagmeet P.
Truong, Quynh A.
CIRCULATION, 2015, 132
[33] Monocyte-to-lymphocyte ratio correlates with parathyroid hormone concentration in patients with severe symptomatic aortic stenosis
Olasinska-Wisniewska, Anna
Urbanowicz, Tomasz
Grodecki, Kajetan
Kubler, Piotr
Perek, Bartlomiej
Grygier, Marek
Misterski, Marcin
Walczak, Maciej
Szot, Mateusz
Jemielity, Marek
ADVANCES IN MEDICAL SCIENCES, 2023, 68 (02): : 396 - 401
[34] N-terminal pro braintype natriuretic peptide (NT-proBNP) is a highly sensitive biochemical marker for surgical therapy in patients with aortic stenosis
Weber, MW
Arnold, R
Rau, M
Maikowski, C
Keil, E
Mitrovic, V
Brandt, R
Hamm, C
CIRCULATION, 2003, 108 (17) : 513 - 513
[35] Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study)
Kruger, Ruan
Rasmussen, Lars M.
Argraves, William S.
Eugen-Olsen, Jesper
Nielsen, Olav W.
Blyme, Adam
Willenheimer, Ronnie
Wachtell, Kristian
Olsen, Michael H.
PLOS ONE, 2014, 9 (07):
[36] NT-proBNP and long-term all-cause mortality in a cohort of patients with type 1 diabetes
Diemar, S. S.
Sejling, A. -S.
Pedersen-Bjergaard, U.
Kistorp, C.
Faber, J.
Thorsteinsson, B.
DIABETOLOGIA, 2012, 55 : S63 - S63
[37] Diagnostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation
Weber, M.
Hausen, M.
Moellmann, H.
Nef, H.
Brandt, R.
Stanisch, M.
Mitrovic, V.
Hamm, C.
EUROPEAN HEART JOURNAL, 2006, 27 : 212 - 212
[38] Low-Flow Severe Aortic Stenosis with Preserved Ejection Fraction, N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiovascular Remodeling
Mizia-Stec, Katarzyna
Adamczyk, Tomasz
Mizia, Magdalena
Haberka, Maciej
Gasior, Zbigniew
Trusz-Gluza, Maria
Tendera, Michal
JOURNAL OF HEART VALVE DISEASE, 2011, 20 (03): : 301 - 310
[39] Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease
Dilek Yazici
Dilek Gogas Yavuz
Ahmet Toprak
Oguzhan Deyneli
Sema Akalin
Acta Diabetologica, 2013, 50 : 155 - 161
[40] Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease
Yazici, Dilek
Yavuz, Dilek Gogas
Toprak, Ahmet
Deyneli, Oguzhan
Akalin, Sema
ACTA DIABETOLOGICA, 2013, 50 (02) : 155 - 161

← 1 2 3 4 5 →